Axogen Inc. (NASDAQ: AXGN) closed the day trading at $7.92 up 1.54% from the previous closing price of $7.80. In other words, the price has increased by $+0.12 from its previous closing price. On the day, 597708 shares were traded.
Ratios:
For a better understanding of AXGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.14 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.71.
On May 09, 2022, Canaccord Genuity Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $10 to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when Zaderej Karen L. sold 39,280 shares for $7.68 per share. The transaction valued at 301,670 led to the insider holds 1,124,565 shares of the business.
Scopelianos Angelo sold 6,881 shares of AXGN for $52,846 on Mar 21 ’24. The Chief R&D Officer now owns 52,999 shares after completing the transaction at $7.68 per share. On Mar 21 ’24, another insider, Donovan Michael Patrick, who serves as the VP Operations of the company, sold 6,033 shares for $7.68 each. As a result, the insider received 46,333 and left with 37,992 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 346.01M and an Enterprise Value of 384.27M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15 while its Price-to-Book (P/B) ratio in mrq is 3.57. Its current Enterprise Value per Revenue stands at 2.42 whereas that against EBITDA is -28.83.
Stock Price History:
Over the past 52 weeks, AXGN has reached a high of $10.83, while it has fallen to a 52-week low of $3.45. The 50-Day Moving Average of the stock is 9.08, while the 200-Day Moving Average is calculated to be 7.22.
Shares Statistics:
Over the past 3-months, AXGN traded about 427.62K shares per day on average, while over the past 10 days, AXGN traded about 418.81k shares per day. A total of 43.12M shares are outstanding, with a floating share count of 40.58M. Insiders hold about 6.08% of the company’s shares, while institutions hold 74.96% stake in the company. Shares short for AXGN as of Mar 15, 2024 were 1.7M with a Short Ratio of 3.97, compared to 1.4M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.93% and a Short% of Float of 4.23%.
Earnings Estimates
Current recommendations for the stock of the company come from 5 analysts. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.02 and a low estimate of -$0.16, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.01 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.03 and -$0.32 for the fiscal current year, implying an average EPS of -$0.16. EPS for the following year is $0.17, with 6 analysts recommending between $0.59 and -$0.04.
Revenue Estimates
6 analysts predict $41.96M in revenue for the current quarter. It ranges from a high estimate of $42.9M to a low estimate of $41.5M. As of the current estimate, Axogen Inc.’s year-ago sales were $36.66M, an estimated increase of 14.40% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $43.61M, an increase of 14.30% less than the figure of $14.40% in the same quarter last year. There is a high estimate of $44.1M for the next quarter, whereas the lowest estimate is $43M.
A total of 6 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $180.5M, while the lowest revenue estimate was $179M, resulting in an average revenue estimate of $179.51M. In the same quarter a year ago, actual revenue was $159.01M, up 12.90% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $202.48M in the next fiscal year. The high estimate is $204.8M and the low estimate is $200M. The average revenue growth estimate for next year is up 12.80% from the average revenue estimate for this year.
